金活医药集团预期上半年拥有人应占亏损约450万元

Core Viewpoint - Kingworld Medicines Group expects a significant decline in profit for the first half of 2025, projecting a year-on-year decrease of approximately 70% to 75%, resulting in a loss of around RMB 4.5 million attributable to shareholders [1] Summary by Category Financial Performance - The company anticipates a profit drop of about 70% to 75% for the first half of 2025, translating to a loss of approximately RMB 4.5 million [1] Business Operations - The decline in performance is primarily attributed to a decrease in gross profit margins of 50% to 55% in the distribution of imported pharmaceutical and health products in China, driven by a slowdown in market demand [1]